Do you want to read an article? Please log in or register.
Patient-Reported Outcomes as Prognostic Indicators for Overall Survival in Cancer: A Systematic Review and Meta-Analysis
Further Publications
Related content
Gastrointestinal Cancer
Circulating tumor DNA as prognostic marker in patients with metastatic colorectal cancer undergoing systemic therapy: A systematic review and meta-analysis
Cancer Treat Rev
Holz A, Paul B, Zapf A, Pantel K, Joosse SA
doi: 10.1016/j.ctrv.2025.102999
Lung, Respiratory and Thoracic Cancer
Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysis
Cancer Treat Rev
Aburaki R, Fujiwara Y, Chida K, Horita N, Nagasaka M
doi: 10.1016/j.ctrv.2024.102833
Genitourinary Cancer
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer
Eur Urol Focus
Kailavasan M, Martini A, Bruins M, Carrion A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Lorch A, Mertens LS, Meijer RP, Mariappan P, Milowsky MI, Neuzillet Y, Panebianco V, Rink M, Thalmann GN, Sæbjørnsen S, van der Heijden T
doi: 10.1016/j.euf.2025.05.024
Further Publications
Frailty and outcomes in adults undergoing systemic anti-cancer treatment: a systematic review and meta-analysis
J Natl Cancer Inst
Pearce J, Martin S, Heritage S, Khoury EG, Kucharczak J, Nuamek T, Cairns DA, Velikova G, Richards SH, Clegg A, Gilbert A
doi: 10.1093/jnci/djaf017
Genitourinary CancerFurther Publications
Radiological progression-free survival as a surrogate for overall survival in patients with metastatic hormone-sensitive prostate cancer: A bivariate meta-analysis
Eur J Cancer
Shore N, Morgans AK, Boegemann M, Gallagher E, Paracha N, Serafini P, Pushkarna D, Pourrahmat MM, Kurt M, Abrams KR
doi: 10.1016/j.ejca.2025.115513
RECOMMENDED
Breast Cancer
Impact of loss of HER2 positivity following neoadjuvant therapy in HER2-positive breast cancer patients on long-term prognosis: A systematic review and meta-analysis
★ 2
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
Cancer Treat Rev
Nakatani S, Hayashi T, Yamamoto K, Maeda H
doi: 10.1016/j.ctrv.2025.102923
Genitourinary Cancer
Efficacy of Treatments for T3bN0M0 Prostate Cancer Patients: A Systematic Review and Meta-Analysis
Prostate
Reijnen C, Heemsbergen WD, Wever KE, Panneflek A, Pos FJ, Michiel Sedelaar JP, van der Heide UA, Incrocci L, Jan Smeenk R
doi: 10.1002/pros.70024
Lung, Respiratory and Thoracic Cancer
Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis
Lung Cancer
Gawli CS, Patil BR, Nagpure NR, Patil CR, Kumar A, Patel HM
doi: 10.1016/j.lungcan.2025.108629
Breast Cancer
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis
Lancet Oncol
Villacampa G, Pascual T, Tarantino P, Cortés J, Perez-García J, Llombart-Cussac A, Conte P, Mancino M, Guarneri V, Dieci MV, Waks AG, Schettini F, Brasó-Maristany F, Griguolo G, de Castro BA, Reboredo C, Antolín S, Bueno-Muiño C, Echavarría I, López-Tarruella S, Massarrah T, Del Monte-Millán M, Martín M, Buckingham W, Parker JS, Vivancos A, Polyak K, Filho OM, Wolff AC, DeMichele A, Tung NM, Perou CM, Paré L, Villagrasa P, Prat A, Tolaney SM
doi: 10.1016/S1470-2045(25)00276-1